Heinrich Kreuzer

Title: Heinrich Kreuzer: Innovator in Lipolytic Pharmaceutical Composition

Introduction

Heinrich Kreuzer is a notable inventor based in Gau-Algesheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of obesity. His innovative work has led to the development of a unique lipolytic composition that addresses this pressing health issue.

Latest Patents

Kreuzer holds a patent for a lipolytic pharmaceutical composition. This composition contains 1-(4-hydroxy-3-dimethylamino-sulfonamidophenyl)-1-hydroxy-2-(1-phenoxy-isopropylamino)ethane or a pharmaceutically acceptable acid addition salt thereof as the active ingredient. The patent outlines a method of combatting obesity using this composition, showcasing his commitment to advancing medical science.

Career Highlights

Heinrich Kreuzer is associated with Boehringer Ingelheim KG, a leading global pharmaceutical company. His work at this esteemed organization has allowed him to focus on innovative solutions for health-related challenges. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.

Collaborations

Kreuzer has collaborated with notable colleagues such as Werner Traunecker and Wilhelm Frolke. These partnerships have fostered an environment of innovation and creativity, contributing to the success of their projects.

Conclusion

Heinrich Kreuzer is a distinguished inventor whose work in lipolytic pharmaceutical compositions has the potential to make a significant impact on obesity treatment. His contributions to the field reflect his dedication to improving health outcomes through innovation.